2-(3-((3-Fluorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 100mg

Ethyl 2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98%, 5g

6-Amino-3',6'-dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one, 95.0%, 5g

Solución de sal disódica EDTA, volumen ROTI® 0,1 mol/l - 0,1 N, ampolla, 1 pieza

2-Fluoro-5-(methylsulfonyl)toluene, 97%, 1g

4-Methyl-N-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)benzenesulfonamide, 98%, 1g

4-Bromobenzene-1,3-diol, 95.0%, 100g

tert-Butyl 4-(2,6-dichloropyridin-4-yl)piperidine-1-carboxylate, 97%, 250mg

(4-Chloro-3-nitrophenyl)(4-fluorophenyl)methanone, 97.0%, 100g

n-(Tert-butyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 98+%, 5g

3-Bromo-2,5-dimethylpyridine, 95.0%, 25g

2-Bromo-5-nitropyrimidine, 95.0%, 1g

4-tert-Butyl-3-methoxybenzoic acid, 97.0%, 25g